交易中 05-13 11:35:07 美东时间
+0.063
+1.31%
今日重点评级关注:HC Wainwright & Co.:维持Protara Therapeutics"买入"评级,目标价从23美元升至27美元;BTIG:维持Black Diamond Therapeutic"买入"评级,目标价从10美元升至11美元
04-30 19:24
UBS analyst Caio Greiner maintains Gerdau (NYSE:GGB) with a Buy and raises the price target from $4.6 to $5.25.
04-30 03:15
Gerdau (NYSE:GGB) reported quarterly earnings of $0.10 per share which missed the analyst consensus estimate of $0.15 by 33.33 percent. This is a 66.67 percent increase over earnings of $0.06 per share from the same
04-28 06:03
Companies Reporting Before The Bell • Alliance Res Partners (NASDAQ:ARLP) is es...
04-27 19:11
今日重点评级关注:Leerink Partners:维持Camp4 Therapeutics"跑赢大市"评级,目标价从8美元升至9美元;韦德布什:维持Arcus Biosciences"跑赢大市"评级,目标价从37美元升至41美元
04-06 16:27
UBS analyst Caio Greiner maintains Gerdau (NYSE:GGB) with a Buy and raises the price target from $4.4 to $4.6.
04-03 02:43
Shares of base metal-related companies are trading lower as investors rotate ou...
03-07 02:23
Wall Street has a short memory. When a new idea captures institutional imaginat...
02-25 01:40
Gerdau posts FY 2025 net income of BRL 1.42 billion, down 69.2% Gerdau posted 4Q25 net sales of BRL 16.97 billion (-5.6% QoQ; +0.9% YoY) on steel shipments of 2.86 million tonnes (-7.3% QoQ; +5.2% YoY). Adjusted EBITDA was BRL 2.37 billion (-13.3% QoQ; -0.7% YoY), with an adjusted EBITDA margin of 1
02-24 05:26
The earnings results for Gerdau (NYSE:GGB) for Q4 were made public on Monday, F...
02-24 05:24